RT Journal Article
SR Electronic
T1 Multi-omics analysis in primary T cells elucidates mechanisms behind disease associated genetic loci
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.07.19.23292550
DO 10.1101/2023.07.19.23292550
A1 Shi, Chenfu
A1 Zhao, Danyun
A1 Rossi, Stefano
A1 Frantzeskos, Antonios
A1 Ding, James
A1 Ferrazzano, Carlo
A1 Wynn, Charlotte
A1 Hum, Ryan
A1 Richards, Ellie
A1 Gupta, Muskan
A1 Yap, Chuan Fu
A1 Plant, Darren
A1 Grencis, Richard
A1 Martin, Paul
A1 Adamson, Antony
A1 Eyre, Stephen
A1 Bowes, John
A1 Barton, Anne
A1 Ho, Pauline
A1 Rattray, Magnus
A1 Orozco, Gisela
YR 2023
UL http://medrxiv.org/content/early/2023/07/23/2023.07.19.23292550.abstract
AB In this study, we present the most extensive dataset of chromatin conformation data with matching gene expression and chromatin accessibility from primary T cells to date. We use this data to enhance our understanding of the different mechanisms by which GWAS variants impact gene regulation and revealing how natural genetic variation alter chromatin accessibility and structure in primary cells at an unprecedented scale. Capitalizing on this vast dataset, we refine the mapping of GWAS loci to implicated regulatory elements, such as CTCF binding sites and other enhancer elements, aiding gene assignment. Importantly, we uncover BCL2L11 as the probable causal gene within the RA locus rs13396472, despite the GWAS variants’ intronic positioning relative to ACOXL and we identify mechanisms involving SESN3 dysregulation in the RA locus rs4409785. Given these genes’ significant role in T cell development and maturation, our work is vital for deepening our comprehension of autoimmune disease pathogenesis and suggesting potential treatment targets.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Wellcome Trust (award references 207491/Z/17/Z and 215207/Z/19/Z), Versus Arthritis (award reference 21754), NIHR Manchester Biomedical Research Centre and the Medical Research Council (award reference MR/N00017X/1).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of The University of Manchester gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes